China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

However, 10 companies defied a broader market optimism, mostly due to a series of stock rating downgrades from investment ...

We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...

For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...

Illumina shares tumbled 8% Friday on investor concerns about the future of the gene-sequencing equipment maker’s business in ...

TD Cowen downgraded Illumina Inc (NASDAQ:ILMN) to "Hold" following the company's fourth-quarter earnings, citing weaker-than-expected next-generation sequencing (NGS) consumable growth, increasing ...

Q4 2024 Earnings Call Transcript February 6, 2025 Illumina, Inc. misses on earnings expectations. Reported EPS is $0.91 EPS, ...

TD Cowen downgraded Illumina (ILMN) to Hold from Buy with a price target of $140, down from $177. Accelerating high throughput next-generation ...

Q4 2024 Management View CEO Jacob Thaysen highlighted the transformative progress Illumina made in 2024, emphasizing its strategic roadmap targeting high single-digit revenue growth by 2027. He noted ...

Angle announces new results for dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform: London Saturday, February 1, 2025, 15:00 Hrs [IST] Angle plc, a wo ...

You may have heard of the big names in the business, like Illumina, Oxford Nanopore Technologies ... lower-throughput solution that brings next-generation sequencing (NGS) to more labs. The core ...